Nan Hu
Impact in
- Cancer Research top 2%
-
- Atrial Fibrillation Management and Outcomes
- Cardiac Arrhythmias and Treatments
- Cardiac electrophysiology and arrhythmias
Papers in
-
- Glaucoma and retinal disorders 9
-
- MicroRNA in disease regulation 8
- Co-authors
- Philip R. TaylorAlisa M. GoldsteinMichael R. Emmert‐BuckChaoyu WangCarol GiffenMaxwell P. LeeHoward H. YangQuanhong Wang
- Journals
- BMC Cancer (6 papers)PLoS ONE (6 papers)Cancer Research (4 papers)Genes Chromosomes and Cancer (4 papers)Clinical Cancer Research (4 papers)
- Partner nations
- ChinaUnited StatesUnited Kingdom
In The Last Decade
Nan Hu
187 papers receiving 6.0k citations
Hit Papers
Peers
Comparison fields: 5 of 162
- Cancer Research 825
- Cardiology and Cardiovascular Medicine 1.1k
- Molecular Biology 2.8k
- Ophthalmology 289
- Immunology 617
Countries citing papers authored by Nan Hu
This map shows the geographic impact of Nan Hu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nan Hu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nan Hu more than expected).
Fields of papers citing papers by Nan Hu
This network shows the impact of papers produced by Nan Hu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nan Hu. The network helps show where Nan Hu may publish in the future.
Co-authors
The 25 scholars most cited alongside Nan Hu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 1 | |
| 2 | 2025 | 0 | |
| 3 | 2025 | 1 | |
| 4 | 2024 | 21 | |
| 5 | 2024 | 3 | |
| 6 | 2024 | 5 | |
| 7 | 2024 | 2 | |
| 8 | 2023 | 3 | |
| 9 | 2022 | 21 | |
| 10 | 2022 | 19 | |
| 11 | 2022 | 3 | |
| 12 | 2022 | 2 | |
| 13 | 2021 | 19 | |
| 14 | 2021 | 6 | |
| 15 | 2021 | 3 | |
| 16 | 2016 | 30 | |
| 17 | Overexpression of Bombyx mori nucleopolyhedrovirus nucleocapsid protein VP39 inhibits the proliferation of BmNPV in BmN-SWU1. | 2015 | 1 |
| 18 | 2014 | 26 | |
| 19 | Association of frizzled-related protein (MFRP) and heat shock protein 70 (HSP70) single nucleotide polymorphisms with primary angle closure in a Han Chinese population: Jiangsu Eye Study. | 2013 | 25 |
| 20 | 2009 | 45 |
About Nan Hu
Nan Hu is a scholar working on Ophthalmology, Cancer Research, Molecular Biology, Pathology and Forensic Medicine and Genetics, having authored 199 papers that have together received 6.1k indexed citations. Recurring topics across this work include RNA modifications and cancer (30 papers), Esophageal Cancer Research and Treatment (21 papers), Cancer-related gene regulation (19 papers), Genetic factors in colorectal cancer (13 papers), Epigenetics and DNA Methylation (13 papers), Glaucoma and retinal disorders (9 papers), Corneal surgery and disorders (8 papers) and MicroRNA in disease regulation (8 papers). The work is most often cited by research in Cancer Research (825 citations), Cardiology and Cardiovascular Medicine (1.1k citations), Molecular Biology (2.8k citations), Ophthalmology (289 citations) and Immunology (617 citations). Nan Hu has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Philip R. Taylor, Alisa M. Goldstein, Michael R. Emmert‐Buck, Chaoyu Wang, Carol Giffen, Maxwell P. Lee, Howard H. Yang, Quanhong Wang, Eugene Kholmovski and Mark J. Roth. Their work appears in journals such as BMC Cancer, PLoS ONE, Cancer Research, Genes Chromosomes and Cancer and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.